Before BMS’ offering, Roche’s PD-L1 inhibitor Tecentriq became the first checkpoint inhibitor to secure a subcutaneous approval from the FDA. Called Tecentriq Hybreza, the injection’s ...

While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on the magnitude of cost increases getting rolled out Jan. 1. All told ...

Since Texas Instruments established the first offshore captive center in Bengaluru in 1985, Global Capability Centers (GCCs) in India have evolved from back-office operations into strategic innovation ...